Increase in R&D budget for Cyberdyne in SIP program Quick Note

Research evidence excerpt

Increase in R&D budget for Cyberdyne in SIP program Quick Note

Global Markets Research

28 July 2026Cyberdyne

7779.T 7779 JP / EQUITY: JAPAN PHARMACEUTICALS

Increase in R&D budget for Cyberdyne in SIP Rating Buyprogram

Target price JPY 400Quick Note

Closing price

28 July 2026 JPY 222Increase in consigned R&D costs for development of social implementation

technologies for HCPS integrated human collaborative robotics under SIP program (Note: Quick Note reports are not a

On 28 July, Cyberdyne announced that consigned R&D costs for the development of vehicle for changes to ratings, target

social implementation technologies for human-cyber-physical space (HCPS) integrated prices, or earnings forecasts)

human collaborative robotics to solve social issues, part of the Cabinet Office's Cross-

ministerial Strategic Innovation Promotion Program (SIP), had been increased from

¥1,348mn to ¥1,891mn (the contract period remains Sep 2023–Mar 2028). Management

is projecting contracted R&D revenues of ¥369mn in 27/3. Our focus is on greater diversity

Research Analystsin monetization of Cybernics technology as HAL implementation and uptake increases

overseas and clinical trials in Japan progress. Japan pharmaceuticals &

healthcare

Focusing on progress with social implementation of Cybernics technology other Kyoichiro Shigemura - NSCthan HAL

kyoichiro.shigemura@nomura.com

This development program has a number of targets, including: (1) autonomous mobile +81 3 6703 1118

robot technologies enabled with Cybernics technology through the use of indoor/outdoor

human and environmental recognition; (2) human-coordinated Cybernics arm robot

technologies; (3) Cybernics technologies to improve mental and physical functions; (4)